MarketPulse

clinical development

65 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Starton Advances Subcutaneous Lenalidomide Program With Phase 2a Multiple Myeloma Trial Launch

Starton launches Phase 2a trial for subcutaneous lenalidomide delivery in multiple myeloma, comparing three dose levels against standard oral Revlimid treatment.
BMYCELGrclinical developmentmultiple myeloma
BenzingaBenzinga··Globe Newswire

Coherus Oncology Raises $50.1M in Stock Offering to Fund Oncology Pipeline

Coherus Oncology raised $50.1M through stock offering to fund commercial launch of LOQTORZI and advance its oncology pipeline development.
CHRSclinical developmentpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Artios Pharma Bolsters Executive Ranks Ahead of Late-Stage Oncology Trials

Artios Pharma appoints three senior executives to strengthen manufacturing, clinical operations, and medical affairs as it advances late-stage oncology trials.
LLYJAZZFDA approvalclinical development
GlobeNewswire Inc.GlobeNewswire Inc.··Okyo Pharma Limited

OKYO Pharma Prices $20M Share Offering to Fund Clinical Development

OKYO Pharma prices $20M share offering to fund clinical development of urcosimod for neuropathic corneal pain treatment, advancing Phase 2b/3 trial.
OKYOPIPRclinical developmentpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Coherus Oncology Raises $50.1M Through Common Stock Offering

Coherus Oncology raises $50.1M via stock offering to fund commercial expansion of LOQTORZI and advance oncology pipeline development programs.
CHRSclinical developmentpublic offering